Robert P. Hebert

Robert P. Hebert discloses dealings in 2 companies, chiefly Bentley Pharmaceuticals Inc and CPEX Pharmaceuticals, Inc. Between 30 June 2007 and 5 April 2011, the trades on record add up to 9 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 7 April 2011 came the latest disclosure, a share grant for €760k in CPEX Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.